Scholarlink

<p>Experimental cancer therapeutics are rapidly advancing, with novel approaches emerging to reduce global cancer burden. This review focuses on challenges hindering the clinical integration of photothermal therapy (PTT), despite its therapeutic potential. Key PTT considerations include photothermal agent (PTA), laser properties and strategies for better application, efficacy and precision. Common parameters for PTA evaluation demonstrate biocompatibility, biodistribution and efficacy assessments. However, for clinical emphasis, targeting efficiency and post-therapy fate determination of PTA, sophisticated engineering of photonic devices, precision assessments as well as pain mitigation are critical. Directed future endeavours, keeping these insights, may facilitate application of PTT as a viable cancer treatment in clinical settings.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Avenues for integrating photothermal therapy in cancer clinic

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月4日

查看全文
  • Chetna Patnaik,
  • Sulagna Rath,
  • Abhijit De

摘要

Experimental cancer therapeutics are rapidly advancing, with novel approaches emerging to reduce global cancer burden. This review focuses on challenges hindering the clinical integration of photothermal therapy (PTT), despite its therapeutic potential. Key PTT considerations include photothermal agent (PTA), laser properties and strategies for better application, efficacy and precision. Common parameters for PTA evaluation demonstrate biocompatibility, biodistribution and efficacy assessments. However, for clinical emphasis, targeting efficiency and post-therapy fate determination of PTA, sophisticated engineering of photonic devices, precision assessments as well as pain mitigation are critical. Directed future endeavours, keeping these insights, may facilitate application of PTT as a viable cancer treatment in clinical settings.